CBIO
Crescent Biopharma Inc.

6,101
Mkt Cap
$327.37M
Volume
20,729.00
52W High
$28.77
52W Low
$8.72
PE Ratio
-0.77
CBIO Fundamentals
Price
$11.63
Prev Close
$11.88
Open
$12.15
50D MA
$11.23
Beta
0.63
Avg. Volume
224,738.22
EPS (Annual)
-$14.78
P/B
1.65
Rev/Employee
$246,454.55
$84.04
Loading...
Loading...
News
all
press releases
Crescent Biopharma (NASDAQ:CBIO) Upgraded to Hold at Wall Street Zen
Wall Street Zen upgraded Crescent Biopharma from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·5d ago
News Placeholder
More News
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Price Target Lowered to $22.00 at HC Wainwright
HC Wainwright decreased their price target on shares of Crescent Biopharma from $25.00 to $22.00 and set a "buy" rating for the company in a research note on Monday...
MarketBeat·10d ago
News Placeholder
Crescent Biopharma, Inc. (NASDAQ:CBIO) Given Consensus Recommendation of "Buy" by Brokerages
Shares of Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) have been assigned a consensus recommendation of "Buy" from the nine ratings firms that are covering the company, Marketbeat.com...
MarketBeat·13d ago
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Stock Passes Above Two Hundred Day Moving Average - Here's What Happened
Crescent Biopharma (NASDAQ:CBIO) Stock Price Passes Above 200 Day Moving Average - Should You Sell...
MarketBeat·14d ago
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Downgraded to Sell Rating by Wall Street Zen
Wall Street Zen downgraded shares of Crescent Biopharma from a "hold" rating to a "sell" rating in a report on Saturday...
MarketBeat·1mo ago
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Upgraded by Guggenheim to Strong-Buy Rating
Guggenheim upgraded Crescent Biopharma to a "strong-buy" rating and set a $35.00 price objective for the company in a research note on Wednesday...
MarketBeat·2mo ago
News Placeholder
Crescent Biopharma (NASDAQ:CBIO) Stock Price Crosses Above Two Hundred Day Moving Average - Here's What Happened
Crescent Biopharma (NASDAQ:CBIO) Share Price Crosses Above 200 Day Moving Average - Here's Why...
MarketBeat·3mo ago
News Placeholder
Crescent Biopharma, Inc. (NASDAQ:CBIO) Receives Average Recommendation of "Buy" from Brokerages
Shares of Crescent Biopharma, Inc. (NASDAQ:CBIO - Get Free Report) have been given a consensus recommendation of "Buy" by the seven brokerages that are currently covering the company, MarketBeat.com...
MarketBeat·3mo ago
News Placeholder
Braidwell LP Invests $4.22 Million in Crescent Biopharma, Inc. $CBIO
Braidwell LP acquired a new stake in Crescent Biopharma, Inc. (NASDAQ:CBIO - Free Report) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange...
MarketBeat·3mo ago
News Placeholder
BVF Inc. IL Makes New Investment in Crescent Biopharma, Inc. $CBIO
BVF Inc. IL purchased a new stake in Crescent Biopharma, Inc. (NASDAQ:CBIO - Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and...
MarketBeat·3mo ago
<
1
2
...
>

Latest CBIO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.